|
Feb 12
|
A Look at Pharma ETFs After Q4 Earnings
|
|
Feb 12
|
This Unstoppable Growth Stock Just Announced More Good News: Is It a Buy?
|
|
Feb 12
|
Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?
|
|
Feb 10
|
CVS chief medical officer: 'We are not looking to build the entire healthcare delivery ecosystem'
|
|
Feb 10
|
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock?
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Feb 10
|
3 Stocks That Could Trounce the Market in 2024
|
|
Feb 10
|
PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves
|
|
Feb 10
|
15 Countries With Highest Pharmaceutical Spend Per Capita
|
|
Jan 16
|
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
|
|
Jan 16
|
Analysts Predict The 10 Most-Valuable Stocks In 12 Months
|
|
Jan 16
|
UPDATE 2-Lilly exec eyes more weight-loss drug launches this year
|
|
Jan 16
|
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|
|
Jan 16
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|
|
Jan 15
|
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
|
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
|
Jan 14
|
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
|
|
Jan 14
|
These 9 Stocks Are Running To Start 2024
|
|
Jan 14
|
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
|
|
Jan 13
|
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
|